- Home
- QNCX vs OPXS Comparison
QNCX vs OPXS Comparison
Compare QNCX & OPXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- OPXS
- Stock Information
- Founded
- QNCX 2012
- OPXS 1987
- Country
- QNCX United States
- OPXS United States
- Employees
- QNCX N/A
- OPXS N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- OPXS Electronic Components
- Sector
- QNCX Health Care
- OPXS Technology
- Exchange
- QNCX Nasdaq
- OPXS Nasdaq
- Market Cap
- QNCX 44.0M
- OPXS 43.4M
- IPO Year
- QNCX 2019
- OPXS N/A
- Fundamental
- Price
- QNCX $1.02
- OPXS $6.58
- Analyst Decision
- QNCX Strong Buy
- OPXS
- Analyst Count
- QNCX 5
- OPXS 0
- Target Price
- QNCX $8.00
- OPXS N/A
- AVG Volume (30 Days)
- QNCX 511.8K
- OPXS 14.6K
- Earning Date
- QNCX 05-16-2025
- OPXS 05-13-2025
- Dividend Yield
- QNCX N/A
- OPXS N/A
- EPS Growth
- QNCX N/A
- OPXS 42.37
- EPS
- QNCX N/A
- OPXS 0.61
- Revenue
- QNCX N/A
- OPXS $35,225,000.00
- Revenue This Year
- QNCX N/A
- OPXS N/A
- Revenue Next Year
- QNCX N/A
- OPXS N/A
- P/E Ratio
- QNCX N/A
- OPXS $10.94
- Revenue Growth
- QNCX N/A
- OPXS 23.22
- 52 Week Low
- QNCX $0.51
- OPXS $5.36
- 52 Week High
- QNCX $2.45
- OPXS $10.30
- Technical
- Relative Strength Index (RSI)
- QNCX 38.15
- OPXS 60.86
- Support Level
- QNCX $0.98
- OPXS $6.56
- Resistance Level
- QNCX $1.16
- OPXS $6.94
- Average True Range (ATR)
- QNCX 0.09
- OPXS 0.23
- MACD
- QNCX 0.00
- OPXS 0.05
- Stochastic Oscillator
- QNCX 20.04
- OPXS 69.23
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About OPXS Optex Systems Holdings Inc.
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.